{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:02:19Z","timestamp":1792479739503,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Kidney transplantation is the optimal treatment for most patients with kidney failure. For patients with a prior history of treated cancers, listing and transplant eligibility decisions are complex. Patients and health professionals are obliged to consider the time-periods between cancer cure and transplantation, the risk of cancer recurrence under the influence of immunosuppression and anti-cancer treatment options if the disease recurs. Cancer recurrence is associated with a high mortality rate, thus potentially reduces the projected survival benefit of transplantation, and dampens the utility of scarce organs. In view of the uncertain risk of harms, clinicians may consider transplantation for candidates with prior cancer history only after an extended period of cancer-free interval, as the fear of disease recurrence and shortened life expectancy may outweigh the benefits of receiving a kidney transplant compared with dialysis. Over the past decade, the evolution of novel anti-cancer therapies coupled with improved understanding of cancer genomics have led to considerable improvement in cancer-free survival. It is therefore justifiable to make individualized transplant suitability decisions based the joint effects of cancer biology, available therapeutic options and prognostic covariates on clinical outcomes. In this review, we first summarized the cancer epidemiology in kidney transplant recipients. We then explored how the probability of cancer cure, risk of recurrence and outcomes in candidates with a prior cancer history may influence the decisions to transplant. Finally, the role of shared decision-making between health professionals and patients regarding the optimal management options, and considerations of patients\u2019 preferences and values are discussed.<\/jats:p>","DOI":"10.1093\/ckj\/sfad141","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T18:51:31Z","timestamp":1687891891000},"page":"1908-1916","source":"Crossref","is-referenced-by-count":8,"title":["Prior cancer history and suitability for kidney transplantation"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-7269","authenticated-orcid":false,"given":"Germaine","family":"Wong","sequence":"first","affiliation":[{"name":"Sydney School of Public Health, University of Sydney , Camperdown, NSW , Australia"},{"name":"Centre for Kidney Research, Kids Research Institute, The Children's Hospital at Westmead , NSW , Sydney, Australia"},{"name":"Centre for Kidney and Transplantation Research, Westmead Hospital , NSW , Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai H","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Renal and Transplantation Medicine, Sir Charles Gairdner Hospital , WA , Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"2023103105001930100_bib1","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/TP.0000000000001774","article-title":"Toward establishing core outcome domains for trials in kidney transplantation: report of the standardized outcomes in nephrology-kidney transplantation consensus workshops","volume":"101","author":"Tong","year":"2017","journal-title":"Transplantation"},{"key":"2023103105001930100_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2215\/CJN.14570920","article-title":"De novo malignancies after kidney transplantation","volume":"17","author":"Al-Adra","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023103105001930100_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41581-018-0022-6","article-title":"Cancer in kidney transplant recipients","volume":"14","author":"Au","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2023103105001930100_bib4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ijc.24439","article-title":"Cancer incidence and risk factors after solid organ transplantation","volume":"125","author":"Vajdic","year":"2009","journal-title":"Int J Cancer"},{"key":"2023103105001930100_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1681\/ASN.2018090906","article-title":"Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant","volume":"30","author":"Au","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"2023103105001930100_bib6","doi-asserted-by":"crossref","first-page":"77771","DOI":"10.18632\/oncotarget.20781","article-title":"Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - a population cohort study","volume":"8","author":"Lim","year":"2017","journal-title":"Oncotarget"},{"key":"2023103105001930100_bib7","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/TP.0000000000004493","article-title":"Variations in risk of cancer and death from cancer according to kidney allograft function, graft loss, and return to dialysis","volume":"107","author":"Au","year":"2023","journal-title":"Transplantation"},{"key":"2023103105001930100_bib8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/annonc\/mdz129","article-title":"Immunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejection","volume":"30","author":"Ros","year":"2019","journal-title":"Ann Oncol"},{"key":"2023103105001930100_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2020.12.015","article-title":"A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant","volume":"100","author":"Murakami","year":"2021","journal-title":"Kidney Int"},{"key":"2023103105001930100_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2215\/CJN.05990616","article-title":"Patterns and predictors of screening for breast and cervical cancer in women with CKD","volume":"12","author":"Wong","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023103105001930100_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.10090916","article-title":"Beliefs and attitudes to bowel cancer screening in patients with CKD: a semistructured interview study","volume":"12","author":"James","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023103105001930100_bib12","doi-asserted-by":"crossref","first-page":"102139","DOI":"10.1016\/j.ctrv.2020.102139","article-title":"Drug dosing in cancer patients with decreased kidney function: a practical approach","volume":"93","author":"Sprangers","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"2023103105001930100_bib13","doi-asserted-by":"crossref","first-page":"e13518","DOI":"10.1200\/JCO.2022.40.16_suppl.e13518","article-title":"International consensus guideline for anticancer drug dosing in kidney dysfunction (ADDIKD): a standardized approach to assessing kidney function in cancer patients and its application to anticancer drug dosing","volume":"40","author":"Sandhu","year":"2022","journal-title":"J Clin Oncol"},{"key":"2023103105001930100_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41581-019-0213-9","article-title":"Strengths and limitations of estimated and measured GFR","volume":"15","author":"Levey","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2023103105001930100_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trre.2017.10.002","article-title":"Cancer evaluation in the assessment of solid organ transplant candidates: a systematic review of clinical practice guidelines","volume":"32","author":"Acuna","year":"2018","journal-title":"Transplant Rev (Orlando)"},{"key":"2023103105001930100_bib16","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"2023103105001930100_bib17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/ajt.16318","article-title":"Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement","volume":"21","author":"Al-Adra","year":"2021","journal-title":"Am J Transplant"},{"key":"2023103105001930100_bib18","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1200\/JCO.21.01195","article-title":"Predicted cure and survival among transplant recipients with a previous cancer diagnosis","volume":"39","author":"Engels","year":"2021","journal-title":"J Clin Oncol"},{"key":"2023103105001930100_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ajt.16324","article-title":"Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: a consensus expert opinion statement","volume":"21","author":"Al-Adra","year":"2021","journal-title":"Am J Transplant"},{"key":"2023103105001930100_bib20","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1097\/TXD.0000000000000716","article-title":"Kidney transplantation in patients with active multiple myeloma: case reports","volume":"3","author":"Lum","year":"2017","journal-title":"Transplant Direct"},{"key":"2023103105001930100_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.trre.2017.08.003","article-title":"Cancer recurrence after solid organ transplantation: a systematic review and meta-analysis","volume":"31","author":"Acuna","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"key":"2023103105001930100_bib22","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/TP.0000000000001286","article-title":"Association of pretransplant skin cancer with posttransplant malignancy, graft failure and death in kidney transplant recipients","volume":"101","author":"Kang","year":"2017","journal-title":"Transplantation"},{"key":"2023103105001930100_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/TP.0000000000002459","article-title":"Pretransplant cancer in kidney recipients in relation to recurrent and de novo cancer incidence posttransplantation and implications for graft and patient survival","volume":"103","author":"Unterrainer","year":"2019","journal-title":"Transplantation"},{"key":"2023103105001930100_bib24","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/TP.0000000000002178","article-title":"Solid organ transplantation in patients with preexisting malignancies in remission: a propensity score matched cohort study","volume":"102","author":"Acuna","year":"2018","journal-title":"Transplantation"},{"key":"2023103105001930100_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/TP.0000000000001192","article-title":"Outcomes of solid organ transplant recipients with preexisting malignancies in remission: a systematic review and meta-analysis","volume":"101","author":"Acuna","year":"2017","journal-title":"Transplantation"},{"key":"2023103105001930100_bib26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cncr.31782","article-title":"Survival after a cancer diagnosis among solid organ transplant recipients in the United States","volume":"125","author":"D'Arcy","year":"2019","journal-title":"Cancer"},{"key":"2023103105001930100_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ajt.2022.11.006","article-title":"Mortality among solid organ transplant recipients with a pretransplant cancer diagnosis","volume":"23","author":"Hart","year":"2023","journal-title":"Am J Transplant"},{"key":"2023103105001930100_bib28","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1097\/TP.0000000000001659","article-title":"Association between pretransplant cancer and survival in kidney transplant recipients","volume":"101","author":"Dahle","year":"2017","journal-title":"Transplantation"},{"key":"2023103105001930100_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: an overview of current strategies and perspectives","volume":"9","author":"Debien","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"2023103105001930100_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1200\/JOP.2014.001434","article-title":"Shared decision making for treatment of cancer: challenges and opportunities","volume":"10","author":"Katz","year":"2014","journal-title":"J Oncol Pract"},{"key":"2023103105001930100_bib31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1055-9965.EPI-21-0929","article-title":"Oncotype DX risk recurrence score and total mortality for early-stage breast cancer by race\/ethnicity","volume":"31","author":"Moore","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2023103105001930100_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.TP.0000442773.38510.32","article-title":"Acute rejection, T-cell-depleting antibodies, and cancer after transplantation","volume":"97","author":"Lim","year":"2014","journal-title":"Transplantation"},{"key":"2023103105001930100_bib33","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20121517","article-title":"Revealing the role of CD4(+) T cells in viral immunity","volume":"209","author":"Sant","year":"2012","journal-title":"J Exp Med"},{"key":"2023103105001930100_bib34","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/ndt\/gfy174","article-title":"Cardiovascular disease in dialysis patients","volume":"33","author":"Cozzolino","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2023103105001930100_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JOP.2017.028480","article-title":"Solid organ transplantation in patients with a history of lymphoma","volume":"14","author":"Bierman","year":"2018","journal-title":"J Oncol Pract"},{"key":"2023103105001930100_bib36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/01.TP.0000140845.10630.4F","article-title":"Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma","volume":"78","author":"Trofe","year":"2004","journal-title":"Transplantation"},{"key":"2023103105001930100_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2018.06.009","article-title":"Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients","volume":"94","author":"Francis","year":"2018","journal-title":"Kidney Int"},{"key":"2023103105001930100_bib38","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/ajt.16385","article-title":"Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: an analysis of the 2000-2019 UNOS\/OPTN database","volume":"21","author":"Leeaphorn","year":"2021","journal-title":"Am J Transplant"},{"key":"2023103105001930100_bib39","article-title":"Survival statistics for non-melanoma skin cancer","author":"Canadian Cancer Society"},{"key":"2023103105001930100_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaad.2021.09.067","article-title":"Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: a nationwide cancer registry study","volume":"86","author":"Tokez","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2023103105001930100_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archdermatol.2009.377","article-title":"Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study","volume":"146","author":"Tessari","year":"2010","journal-title":"Arch Dermatol"},{"key":"2023103105001930100_bib42","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00007890-200011270-00015","article-title":"Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study","volume":"70","author":"Naldi","year":"2000","journal-title":"Transplantation"},{"key":"2023103105001930100_bib43","first-page":"26","article-title":"Should a kidney transplant be performed in a patient with multiple myeloma","volume":"14","author":"Kala","year":"2022","journal-title":"ASN Kidney News"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfad141\/50781897\/sfad141.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/11\/1908\/52692160\/sfad141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/11\/1908\/52692160\/sfad141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:41:50Z","timestamp":1698734510000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/16\/11\/1908\/7209910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6,28]]},"published-print":{"date-parts":[[2023,10,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfad141","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,6,28]]}}}